glucose, (beta-d)-isomer has been researched along with Arrhythmias, Cardiac in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 12 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, GW; Du, L; Hu, Z; Ju, F | 1 |
| Giannakoulas, G; Kotsa, K; Koufakis, T; Zebekakis, P | 1 |
| Dai, C; Fang, J; Huang, H; Kong, B; Qin, T; Shuai, W; Xiao, Z | 1 |
| Chang, R; Cui, B; Fan, Z; Hiram, R; Huang, C; Huang, H; Liu, T; Shi, S; Su, X; Tang, Y; Wu, G; Wu, J; Xiong, F; Yan, M; Zhang, W | 1 |
| Güzel, T; İnci, Ü | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Jaiwongkam, T; Kerdphoo, S; Lahnwong, S; Palee, S; Sriwichaiin, S | 1 |
| Chang, SL; Chen, SA; Chung, FP; Higa, S; Hsiao, YW; Hu, YF; Huang, YT; Lin, SF; Lin, YJ; Liu, SH; Lo, LW; Tsai, YN | 1 |
| Chu, X; Guan, S; Jin, W; Liang, Y; Wang, H; Xue, Y; Zhang, J; Zhang, Y | 1 |
| Chang, CP; Chang, WT; Chen, CY; Chen, ZC; Cheng, BC; Fisch, S; Ho, CH; Lin, MT; Lin, YW; Shih, JY | 1 |
| Azam, MA; Chakraborty, P; Du, B; Ha, ACT; Lai, PFH; Massé, S; Nanthakumar, K; Si, D | 1 |
| Chen, SY; Chen, WT; Lee, CC; Lee, TM | 1 |
| Bengtsson, O; Curtain, JP; Docherty, KF; Inzucchi, SE; Jhund, PS; Kosiborod, MN; Køber, L; Langkilde, AM; Martinez, FA; McMurray, JJV; Petrie, MC; Ponikowski, P; Sabatine, MS; Sjöstrand, M; Solomon, SD | 1 |
| Fan, Z; Luo, X; Lv, N; Tan, W | 1 |
| Akkus, E; Degirmenci, S; Durak, A; Olgar, Y; Tuncay, E; Turan, B | 1 |
| Austria, JA; Garg, B; Netticadan, T; Parikh, M; Pierce, GN; Raj, P; Yu, L | 1 |
| Feng, C; Gao, XP; Li, BG; Qi, HY; Zhang, GL | 1 |
| BALZER, R; IVANCIC, R; VODOPIVEC, M | 1 |
| Briedis, V; Kucinskaite, A; Savickas, A | 1 |
| GOLDBERG, L | 1 |
| Chen, CF; Chen, YF; Lin, YT; Tsai, HY | 1 |
| Higuchi, H; Kinjo, J; Nohara, T | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Arrhythmias, Cardiac
| Article | Year |
|---|---|
[Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine].
Topics: Adaptation, Physiological; Adult; Animals; Anti-Arrhythmia Agents; Antidepressive Agents; Antineoplastic Agents; Antioxidants; Arrhythmias, Cardiac; Central Nervous System; Clinical Trials as Topic; Depression; Glucosides; Humans; Lymnaea; Medicine, Traditional; Mental Fatigue; Neoplasms; Phenols; Phenylethyl Alcohol; Phytotherapy; Plant Extracts; Plant Preparations; Rats; Resins, Plant; Rhodiola | 2004 |
2 trial(s) available for glucose, (beta-d)-isomer and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.
Topics: Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Calcium; Connexin 43; Disease Models, Animal; Fura-2; Glucose; Glucosides; Heart Failure; Monocrotaline; Pulmonary Arterial Hypertension; Rats; Sodium; Ventricular Dysfunction, Right; Ventricular Remodeling | 2022 |
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
Topics: Arrhythmias, Cardiac; Benzhydryl Compounds; Death, Sudden; Death, Sudden, Cardiac; Glucosides; Heart Arrest; Heart Failure; Humans; Male; Stroke Volume; Ventricular Function, Left | 2021 |
18 other study(ies) available for glucose, (beta-d)-isomer and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death.
Topics: Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Death, Sudden, Cardiac; Disease Models, Animal; Glucosides; Heart Rate; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphorylation; Rats, Sprague-Dawley; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
The effect of dapagliflozin on ventricular arrhythmias, cardiac arrest, or sudden death in people with heart failure: a tick in another box for sodium-glucose cotransporter 2 inhibitors.
Topics: Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Death, Sudden; Glucose; Glucosides; Heart Arrest; Heart Failure; Humans; Sodium; Stroke Volume; Ticks | 2022 |
Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline.
Topics: Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Disease Models, Animal; Glucosides; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2022 |
The effect of empagliflozin on index of cardio-electrophysiological balance in patients with diabetes mellitus.
Topics: Arrhythmias, Cardiac; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Failure; Humans; Male | 2023 |
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury.
Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Benzhydryl Compounds; Disease Models, Animal; Energy Metabolism; Glucosides; Male; Mitochondria, Heart; Mitochondrial Dynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Rhodiola crenulata reduces ventricular arrhythmia through mitigating the activation of IL-17 and inhibiting the MAPK signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Arrhythmias, Cardiac; CD4 Lymphocyte Count; Chemokine CCL20; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Electrocardiography; Glucosides; Inflammation Mediators; Interleukin-17; MAP Kinase Signaling System; NLR Family, Pyrin Domain-Containing 3 Protein; Phenols; Rabbits; Rhodiola; RNA, Messenger; Signal Transduction | 2021 |
Inhibitory effects of four active components in saffron on human ether-a-go-go-related gene (hERG) K+ currents.
Topics: Arrhythmias, Cardiac; Carotenoids; Crocus; Cyclohexenes; ERG1 Potassium Channel; Glucosides; Humans; Phytochemicals; Terpenes; Vitamin A | 2020 |
Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation-Induced Myocardial Dysfunction.
Topics: Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Disease Models, Animal; Glucosides; Hemodynamics; Male; Mitral Valve Insufficiency; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Anti-arrhythmic and inotropic effects of empagliflozin following myocardial ischemia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzhydryl Compounds; Calcium; Glucosides; Male; Myocardial Ischemia; Rabbits; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Dapagliflozin attenuates arrhythmic vulnerabilities by regulating connexin43 expression via the AMPK pathway in post-infarcted rat hearts.
Topics: AMP-Activated Protein Kinases; Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Connexin 43; Gene Expression; Glucosides; Male; Myocardial Infarction; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Remodeling | 2021 |
Isosteviol prevents the prolongation of action potential in hypertrophied cardiomyoctyes by regulating transient outward potassium and L-type calcium channels.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channels, L-Type; Cardiomegaly; Diterpenes, Kaurane; Glucosides; Myocardium; Myocytes, Cardiac; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2017 |
A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Blood Glucose; Disease Models, Animal; Glucosides; Heart Rate; Heart Ventricles; Insulin; Insulin Resistance; Male; Membrane Potential, Mitochondrial; Metabolic Syndrome; Mitochondria, Heart; Myocytes, Cardiac; Potassium Channels, Voltage-Gated; Rats, Wistar; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Function, Left; Voltage-Gated Sodium Channels | 2018 |
Dietary flaxseed protects against ventricular arrhythmias and left ventricular dilation after a myocardial infarction.
Topics: alpha-Linolenic Acid; Animals; Arrhythmias, Cardiac; Body Weight; Butylene Glycols; Cardiotonic Agents; Dietary Supplements; Electrocardiography; Fatty Acids; Flax; Glucosides; Male; Myocardial Infarction; Myocarditis; Organ Size; Rats, Sprague-Dawley; Ventricular Remodeling | 2019 |
A new triterpene and an antiarrhythmic liriodendrin from Pittosporum brevicalyx.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Furans; Glucosides; Male; Phytotherapy; Plant Bark; Plant Extracts; Plant Leaves; Rats; Rats, Sprague-Dawley; Rosales; Triterpenes; Ventricular Fibrillation; Verapamil | 2010 |
[Combined administration of cardiotonic glucosides and dihydrated sympathicolytics of the ergotoxin group in tachycardia].
Topics: Arrhythmias, Cardiac; Cardiac Glycosides; Cardiotonic Agents; Glucosides; Glycosides; Heart; Humans; Tachycardia | 1950 |
Cardiac irregularity and respiratory arrest in assay of cardiac glucosides by the guinea-pig method.
Topics: Arrhythmias, Cardiac; Glucosides; Guinea Pigs; Heart; Heart Arrest; Respiration | 1949 |
The interactions of paeoniflorin and veratrine on isolated rat atria.
Topics: Animals; Arrhythmias, Cardiac; Benzoates; Bridged-Ring Compounds; Calcium Channels; Glucosides; Heart Atria; Herb-Drug Interactions; In Vitro Techniques; Male; Monoterpenes; Myocardial Contraction; Phytotherapy; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Sodium Channels; Time Factors; Veratrine | 1997 |
An arrhythmic-inducing glycoside from Albizzia julibrissin Durazz, IV.
Topics: Animals; Arrhythmias, Cardiac; Drugs, Chinese Herbal; Glucosides; Magnetic Resonance Spectroscopy; Myocardial Contraction; Pyridoxine; Ranidae; Spectrometry, Mass, Fast Atom Bombardment | 1992 |